Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-centre, Open-label, First-in-man Study With Dehisgel Used in Adult Patients Undergoing Colorectal Anastomosis Due to Rectal Cancer.

NCT07490080 is registered in ClinicalTrials.gov with Contipro Pharma a.s. as lead sponsor.

NCT NCT07490080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07490080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-centre, Open-label, First-in-man Study With Dehisgel Used in Adult Patients Undergoing Colorectal Anastomosis Due to Rectal Cancer.
Lead sponsor
Contipro Pharma a.s.
Phase
Observational
Overall status
Terminated
Start date
October 23, 2024
Completion date
December 30, 2025
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anastomosis, leaking